Feedback plc
Feedback signs collaboration agreement with a provider of
primary care solutions
Feedback plc ("Feedback" or the
"Company"), has signed a collaboration agreement with a provider of
primary care solutions to explore the opportunities for a novel
Neighborhood Diagnostics Solution.
The intention is to explore creating
a solution that combines the partners' technology and Bleepa to
streamline NHS diagnostic and pathway referrals between primary
care, Community Diagnostic Centres (CDCs) and secondary care. It is
envisaged the solution will also enable some diagnostic procedures
to be referred into community settings such as pharmacy or other
diagnostic facilities, creating additional diagnostic capacity
to support NHS waitlist recovery.
The parties intend to pilot the
solution before pursuing broader national opportunities for
contracts. Pilot conversations with customer sites are already
underway. A pilot will seek to demonstrate both the continued
reduction in outpatient appointment requirement through the
combined platform, further reduction in patient wait times through
an optimised GP referral process and also the ability to scale the
solution at pace to multiple GP practices
simultaneously.
The collaboration provides a route
to rapidly scale the Bleepa solution and pathway approach,
leveraging the existing footprint of the party.
The Company estimates that over 190m
diagnostic tests per year could be redirected to a pharmacy
setting. If taken to a national scale this opportunity could
represent an estimated total addressable market of £382m annually
with further opportunities for potential international
expansion. Commercial revenue from this potential opportunity
remains subject to, inter
alia, successful pilots and commercial agreement between the
parties.
Dr
Tom Oakley, CEO, Feedback plc said: "This collaboration aligns
to the Secretary of State's vision to move care out of traditional
acute provider settings and into the community, closer to patients.
If successful it will provide additional capacity to the NHS and
help to overcome some of the difficulties being faced by CDCs, such
as recruitment challenges, by enabling redirection to fully staffed
facilities. It will also offer patients' choice and the convenience
of attending their local high street for routine NHS investigations
with, we believe, shorter wait
times.
"Lord Darzi's paper, released on Thursday 12th
September, calls directly for this solution. Given the impact that
the combined product can deliver and the ability to leverage our
partners existing footprint to scale the solution the Company
believes that we have a huge opportunity to support the new model
of the NHS under the new Labour Administration."
This announcement contains inside
information for the purposes of Article 7 of Regulation (EU) No
596/2014 as it forms part of UK law by virtue of the
European Union (Withdrawal) Act 2018.
--Ends--
Enquiries:
Feedback plc
Tom Oakley, CEO
Anesh Patel, CFO
|
+44 (0) 20 3997 7634
IR@fbk.com
|
|
|
Panmure Liberum Limited (NOMAD and Broker)
Emma Earl/Freddy Crossley/Mark
Rogers (Corporate Finance)
Rupert Dearden (Corporate
Broking)
|
+44 (0)20 7886 2500
|
|
|
Walbrook PR Ltd;
|
Tel: 020 7933 8780 or
feedbackplc@walbrookpr.com
|
Nick Rome/Joe Walker
|
07748 325 236 or 07407 020
470
|
About Feedback
Feedback plc helps clinical teams to
make better decisions faster for patients. We design products that
enhance clinician access to patient data and to their colleagues.
Our unique approach centres around individual patient episodes,
into which we pull relevant clinical data from hospital systems and
around which we build remote clinical teams for collaboration. As a
result, we produce a digital infrastructure that makes patient data
available to clinicians in multiple settings, in a format that
enables them to meaningfully interact with it, providing
flexibility to clinicians and free movement of patients between
provider settings - clinicians can practice from anywhere and
patients can attend any care provider for treatment, with greater
connectivity across organisations.
Our products Bleepa® and CareLocker®
work together to deliver unparalleled value to our customers.
Bleepa® is our application layer and sits on top of CareLocker® as
our data layer. Bleepa® is a clinician facing platform that
displays clinical results from a patient's CareLocker® at a
certified and regulated quality, that is suitable for clinical use
and enables dialogue on a patient-by-patient basis with colleagues
through a secure, auditable chat interface that links back to the
patient medical record. The CareLocker® data storage model is built
around the patient. Our vision is one where relevant clinical data
is always available to the patient as well as to any care setting
that they may attend - a federated data architecture with the
patient as the tenant.
The Company has a number of growth
opportunities domestically and internationally across a range of
markets including the NHS, the veterinary market and private
healthcare providers and its highly scalable Software as a Service
("SaaS")-based model is expected to provide increasing levels of
revenue visibility as the Company grows its customer
base.